In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Cubist buys TerraGen in $29mm stock swap

Executive Summary

Anti-infectives developer Cubist Pharmaceuticals has purchased privately held TerraGen Discovery (biodiversity small-molecule drug discovery) for $29mm in stock. Cubist will issue 608,000 of its common shares in exchange for all of TerraGen's outstanding shares.
Deal Industry
  • Biotechnology
    • Drug Discovery Tools
      • Molecular Diversity
        • Natural Products
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Payment Includes Stock
    • Intra-Biotech Deal
    • Full Acquisition
    • Includes Contract

Related Companies

Advertisement
UsernamePublicRestriction

Register